Sarepta shares fall 37% as FDA questions future of key gene therapy
Shares of Sarepta Therapeutics fell close to 37% on Friday after reports emerged that the US Food and Drug Administration…
Shares of Sarepta Therapeutics fell close to 37% on Friday after reports emerged that the US Food and Drug Administration…
Talen Energy (NYSE: TLN) shares surged over 25% on Friday, reaching $330.99 in intraday trading and setting a new all-time…
Donald Trump filed a sweeping lawsuit against media magnate Rupert Murdoch, News Corp, Dow Jones, and two Wall Street Journal…
The visa ban imposed by the United States against several high-ranking Brazilian judicial officials, including Supreme Court Justice Alexandre de…
For a long time, global concern focused on the threat of overpopulation, too many people straining Earth’s resources. But lately,…
Amazon Web Services (AWS), the cloud computing wing of Amazon, laid off several hundred employees on Thursday as part of…
Japan’s key measure of consumer prices cooled slightly more than expected in June, but remained well above the Bank of…
Israel’s stock market has defied the odds to become the strongest performer in the Middle East over the past 22…
Swedish defense group Saab reported stronger-than-expected second-quarter earnings and raised its 2025 sales guidance, as rising global defense budgets continue…
China is reportedly threatening to obstruct the sale of over 40 ports, currently owned by Hong Kong-based CK Hutchison, to…